Why the study?
Stanford Type B acute aortic dissection carries high mortality with complex treatment choices influenced by duration and complication status.
Population
23 patients treated for Stanford Type B acute aortic dissection
Comparison
Medical treatment vs TEVAR vs open surgery
Design
Single-center retrospective study
Key result
In a cohort of 23 patients with Stanford Type B acute aortic dissection, total mortality was 13% and 30-day survival was 86.9%, with no mortality observed in the TEVAR group.
Authors
Loading...
Supports medical Rx for uncomplicated Type B-AAD and TEVAR for complicated; leaves open need for larger prospective data.
Observational (n=23)
No
In a small retrospective cohort, treating uncomplicated Type B aortic dissection with medical therapy and complicated cases with TEVAR or open surgery resulted in an 86.9% 30-day survival rate.
Demir et al. (2019) conducted an observational in Stanford Type B acute aortic dissection (n=23). Treatment strategies (Conventional Medical Treatment, TEVAR, Open Surgery) was evaluated on Total mortality. In a cohort of 23 patients with Stanford Type B acute aortic dissection, total mortality was 13% and 30-day survival was 86.9%, with no mortality observed in the TEVAR group.